Generated by Rank Math SEO, this is an llms.txt file designed to help LLMs better understand and index this website.

# Eurocor Tech GmbH: one heartbeat ahead

## Sitemaps
[XML Sitemap](https://eurocor.de/sitemap_index.xml): Includes all crawlable and indexable pages.

## Posts
- [FREEWAY™ 035 Long Term Study Published](https://eurocor.de/freeway-035-long-term-study-published): Eurocor Tech is proud to announce that the positive 5-year results¹ of the Freeway long-term study² have now been officially published in CVIR – the official journal of the Cardiovascular and Interventional Radiological Society of Europe (CIRSE).
- [Eurocor at LINC 2024](https://eurocor.de/eurocor-at-linc-2024): The LINC annual congress features state-of-the-art lectures and live cases from leading interventional centers. After more than 10 years of continuous growth, LINC has proven to be a pillar of scientific and industry conversation around improving vascular treatment technologies. We are proud to announce the presentation of Eurocor’s 5 year FREEWAY™ safety and efficacy data at LINC 2024 conference in Leipzig, Germany. Titel: 5-Jahres Nachbeobachtungsdaten und Sterberate der randomisierten Freeway Stent Studie
- [Eurocor at IROS 2024](https://eurocor.de/eurocor-at-iros-2024): We are proud to announce the presentation of Eurocor’s 5 year FREEWAY™ safety and efficacy data at IROS 2024 conference in Salzburg, Austria. Titel: 5-Jahres Nachbeobachtungsdaten und Sterberate der randomisierten Freeway Stent Studie
- [Eurocor at CIRSE 2023](https://eurocor.de/eurocor-at-cirse-2023): We are proud to announce that Eurocor’s 5 year FREEWAY™ safety data will be part of the scientific program during CIRSE 2023 in Copenhagen. The data’s presentation will be part of the FIRST@CIRSE session, which features important first data releases in the IR field.  
- [Eurocor at LINC 2023](https://eurocor.de/eurocor-at-linc-2023): The LINC annual congress features state-of-the-art lectures and live cases from leading interventional centers. After more than 10 years of continuous growth, LINC has proven to be a pillar of scientific and industry conversation around improving vascular treatment technologies. The Eurocor team will be available at the conference from 6 - 9 June. Please contact your sales representative to schedule an onsite meeting.
- [Eurocor at EuroPCR 2023](https://eurocor.de/eurocor-at-europcr-2023): The World-Leading Course in interventional cardiovascular medicine, EuroPCR, will take place 16 - 19 May in Paris. We look forward to meeting you personally at the conference. We are looking forward to welcoming you at the event. Please contact your sales representative to schedule an onsite meeting.
- [Eurocor at IROS 2023](https://eurocor.de/iros-2023): We are proud to announce the presentation of Eurocor’s 5 year FREEWAY™ safety data at IROS 2023 conference in Salzburg, Austria. Title: Langzeitnachuntersuchung und Sterberate der Patienten der Freeway Stent Studie  
- [Eurocor at CIRSE 2022](https://eurocor.de/eurocor-at-cirse-2022): We are proud to announce that Eurocor’s 5 year FREEWAY™ safety data will be part of the scientific program (Room 115, Sun. 11th) at CIRSE 2022 conference in Barcelona. We are looking forward to welcoming you at the event, where be present with a booth (#64). Please contact your sales representative to schedule an onsite meeting. Our team will be present from Sept. 10th - 14th.  
- [Eurocor at EuroPCR 2022](https://eurocor.de/europcr-2022): After a long time of restrictions and online conferences, EuroPCR organization is opening its doors to meet, to learn and exchange expertise in person. We – at Eurocor Tech – are very happy about this first possibility to meeting you personally again. We are looking forward to welcoming you at the event. Please contact your sales representative to schedule an onsite meeting.  
- [Eurolimus™: award of CE mark and start of commercial sale](https://eurocor.de/eurolimus_launch): Eurocor is proud to announce the CE-marking and commercial launch of Eurolimus™.
- [Eurocor at LINC 2021](https://eurocor.de/linc-2020): We are proud to announce that Eurocor’s FREEWAY Stent study (used stent type subgroup analysis) will be part of the selected abstracts during LINC 2021 (January 25th – 29th, 2021).
- [New Training Module: Cost Effectiveness of DCBs](https://eurocor.de/training_module_cost_effectiveness): Discover our new training module on the cost-efficiency of DCB treatment compared to alternative intervention options. You can sign up for a training through your sales representative directly or by reaching out to info@eurocor.de.
- [Eurocor at ISICAM 2020](https://eurocor.de/isicam-2020): For the first time this year, ISICAM will be held as a digital conference. Stop by our booth to check out of latest study results and learn about our innovative products such as FREEWAY™ long length catheters.
- [Eurocor at CIRSE Congress 2020 e-Summit](https://eurocor.de/cirse-2020): Eurocor will participate in the 2020 CIRSE e-congress and present new results and subgroup analysis of the Effect of the stent type on hemodynamic and clinical outcome in the randomized Freeway Stent Study. The presentation will be available on demand for registred participants.
- [FREEWAY™ long lengths (190 & 230 mm) available now!](https://eurocor.de/freeway_long_lengths): Discover Eurocor's new long-length drug coated balloon catheters specifically designed for peripheral intervention of long and challenging lesions.
- [Eurocor wins Top Poster Award at IROS 2020](https://eurocor.de/eurocor-wins-top-poser-award-at-iros-2020): Eurocor recieved the TOP Poster award for the presentation of subgroup analysis from the randomized Freeway Stent Study at the 2020 LINC interventional congress in Leipzig, Germany.
- [Eurocor at IROS 2020 Congress](https://eurocor.de/iros-2020): From January 16th – 18th 2020 Eurocor Tech will be present at IROS 2020, Dreiländertagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Interventionelle Radiologie (DeGIR, ÖGIR & SSVIR).
- [Eurocor at LINC 2020](https://eurocor.de/linc2020): Eurocor Tech will be present at LINC - The 2020 LEIPZIG INTERVENTIONAL COURSE. Come visit our booth and do not miss our Poster Presentation on benefits of DEB post stenting, held January 29th, Room 7 – Speaker’s corner, 13:30 – 15:00.
- [Eurocor at MYLIFE 2019](https://eurocor.de/mylife-2019): Eurocor will participate in the 2019 MYLIVE congress held in Malaysia. We are looking forward to welcoming you at our booth, D34.

## Pages
- [Contact](https://eurocor.de/contact)
- [Clinical research](https://eurocor.de/clinical-research)
- [Eurocor](https://eurocor.de/eurocor)
- [Press](https://eurocor.de/eurocor/press): Eurocor Tech is a rapidly growing European Life Sciences Technology corporation specializing in the research, development and manufacture of interventional cardiovascular and endovascular treatment devices made in Europe for the world.
- [Jobs & Career](https://eurocor.de/eurocor/jobs-career): Then we look forward to receiving your informative application documents stating your salary expectations and the earliest possible starting date. We ask for your understanding that paper documents cannot be considered.
- [News](https://eurocor.de/news)
- [Home](https://eurocor.de/)

## Jobs
- [Initiativbewerbung / Initiative Application (VZ/TZ) (m/w/d)](https://eurocor.de/eurocor/jobs-career/initiativ-bewerbung-m-w-d)

## Landingpage

## Products
- [FREEWAY™ AV Shunt](https://eurocor.de/freeway-av-shunt): The FREEWAY™ 035 AV Paclitaxel-eluting PTA balloon dilatation catheter is an over-the-wire (OTW) catheter which is specially designed for peripheral arteriovenous (AV) interventions in dialysis patients. It is indicated for widening stenosis of de novo and restenotic AV fistulas and shunt graft lesions to reduce re-interventions and to preserve future treatment options.
- [Eurolimus™](https://eurocor.de/eurolimus): The EUROLIMUS™ Sirolimus eluting coronary stent system is made of a coated cobalt-chromium alloy (L605) stent and a rapid-exchange catheter. Eurolimus is indicated for use in patients with symptomatic ischemic coronary heart disease due to de novo lesions or restenosed lesions of the coronary arteries. The stent system is also indicated for the treatment of acute or suspected occlusions in patients who respond unsuccessfully to an interventional therapy following balloon dilatation.
- [DIOR®](https://eurocor.de/dior): The DIOR®, a Paclitaxel-eluting PTCA balloon dilatation catheter, is a rapid-exchange catheter which is specially designed for interventions in coronary arteries. It is indicated for widening stenosis of de novo and restenotic lesions of a coronary artery or a coronary bypass in order to enhance myocardial perfusion. The DIOR® Paclitaxel eluting coronary balloon catheter is especially indicated for the treatment of coronary in-stent restenosis.
- [FREEWAY™ 035](https://eurocor.de/freeway-035): The FREEWAY™ 035 Paclitaxel-eluting PTA balloon dilatation catheter is an over-the-wire (OTW) catheter which is specially designed for peripheral interventions in femoral-popliteal lesions. It is indicated for widening stenosis of de novo and restenotic lesions in the iliac, femoral, iliac-femoral, popliteal, infra-popliteal and renal arteries. This balloon is also used for post-dilatation after stent implantation in the peripheral vascular system.
- [FREEWAY™ 014](https://eurocor.de/freeway-014): The FREEWAY™ 014 Paclitaxel-eluting PTA balloon dilatation catheter is an over-the-wire (OTW) catheter which is specially designed for peripheral interventions in infra-popliteal lesions. It is indicated for widening stenosis of de novo and restenotic lesions in the iliac, femoral, iliac-femoral, popliteal, infra-popliteal and renal arteries. This balloon is also used forpost-dilatation after stent implantation in the peripheral vascular system.

## Clinical research
- [Preclinical Program Freeway™](https://eurocor.de/clinical-research/preclinical-freeway)
- [Preclinical Program DIOR®](https://eurocor.de/preclinical-dior)
- [Bloodplasma Analysis FREEWAY™ DEB](https://eurocor.de/bloodplasma-analysis-freeway-deb)
- [Bloodplasma Analysis DIOR® DEB](https://eurocor.de/bloodplasma-analysis-dior-deb)
- [Cytotoxicity Analysis DEB](https://eurocor.de/cytotoxicity-test-deb)
- [DEB in PAD](https://eurocor.de/clinical-research/pad): The FREEWAY™ drug-eluting balloon proved safety and efficacy in peripheral arterial disease. Learn more about Eurocor Tech`s DEB studies in PAD.
- [DEB in AV Shunt](https://eurocor.de/shunt): The FREEWAY™ drug-eluting balloon proved safety and efficacy in AV fistula and shunt lesions. Learn more about our studies in arteriovenous lesions.
- [DEB in CAD](https://eurocor.de/clinical-research/clinical-research-cad): The DIOR® drug-eluting balloon proved safety and efficacy in coronary arterial disease. Learn more about Eurocor Tech`s DEB studies in CAD.
- [DES in CAD](https://eurocor.de/clinical-research/des-in-cad): Drug-eluting stents are the established treatment options for coronary arterial disease. Learn more about Eurolimus™ DES studies in CAD.